Market Currents

Arena Pharma (ARNA +4.1%) adds to sharp gains from yesterday as LifeSci Advisors publishes an...

Wednesday, August 15, 2012, 9:33 AM ET
Arena Pharma (ARNA +4.1%) adds to sharp gains from yesterday as LifeSci Advisors publishes an upbeat note about the stock. LifeSci's main points include Arena possibly receiving a $1.2B one-time purchase price adjustment from its partner Eisai based on net sales of diet drug Belviq.

This Market Current was sent to 12,028 people who get email alerts on ARNA.

Get email alerts on ARNA »

Share this Market Current

Short URL:

Track new comments on this story

This news story has 7 comments:

user418 Comments (88)

THAT IS TOO LOW!!!!!!!!!!!!!!!!!

15 Aug 2012, 11:12 AM Reply Like

cowpie006 Comments (3)

I second this opinion.

15 Aug 2012, 02:03 PM Reply Like

vitosoranno1 Comments (458)

I third the opinion.

The proposal, if true, makes no sense at all.

27 Aug 2012, 04:41 PM Reply Like

misa1969 Comments (2)

buy out for $1.2B is not bad

15 Aug 2012, 11:42 AM Reply Like

democratic Comments (2)

way too low say price per share

15 Aug 2012, 01:38 PM Reply Like

Darrellt Comments (50)

Worse than absurdly low! It is amazing how many people do not understand the impact of Belviq.

15 Aug 2012, 02:01 PM Reply Like

New Superhuman Comments (834)

People can understand Belviq. The institutional traders are manipulating the price down to pry as many shares as possible from weak retail hands. The relentless selling (while institutions are accumulating in dark pools. Who said this was a free market?), the relentless FUDsters - you know who they are - who squawk about how Belviq is useless, the company a fraud, etc.

The games will be over soon, and the price will soar to new highs. I retire early and live happily ever after. Hint: use options for leverage.

16 Aug 2012, 03:00 AM Reply Like

LATEST|

TODAY SO FAR|

YESTERDAY

Other date

DJIA (DIA) S&P 500 (SPY)